Information Library

Results for: Market Access

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title
  • Quintiles Forms New Biomarker Research and Development Company

    Press Release — January 18, 2012 – Quintiles announced that it has invested in a new company formed to provide oncology consulting services and new cancer biomarkers, the key to scientific selection of the right drug for the right patient.

  • ISPOR Europe 2012

    EventConference Date(s): November 3 - November 7, 2012
    Location: Berlin, German

  • ISPOR US 2012

    EventConference Date(s): June 2 - June 6, 2012
    Location: Washington, DC

  • Franchise Influence and Leverage Mapping

    Brochure — November 10, 2011
    In this industry it’s not just whom you know, but who knows you and how far their sphere of influence reaches.

  • How Informative is Your Segmentation?

    Hear from the Experts — September 15, 2011
    Article published by Quintiles' Pieter Sheth-Voss in the Winter 2010 issue of Market Research magazine was recently awarded the David K. Hardin Memorial Award for 2011.

  • Quintiles Market Research Expert Honored by American Marketing Association Foundation

    Press Release — September 15, 2011 – Quintiles announced that The American Marketing Association (AMA) Foundation selected an article co-authored by Pieter Sheth-Voss, of Consulting at Quintiles, to receive the 2011 David K. Hardin Award.

  • Shifting Sands

    Media Coverage — September 2, 2011
    As the pressure to improve the productivity of clinical development programmes mounts on pharmaceutical companies, the current landscape for locating cost-effective clinical trials continues to evolve. One region attracting attention is the Middle East and North Africa.

  • Malaria Prevention in Sub-Saharan Africa

    Case Study — June 24, 2011
    This study enabled us to be involved in bringing a malaria vaccine to Africa which could substantially reduce an infant mortality rate that currently stands

  • Advancing Vaccine Development in Australia and New Zealand

    Case Study — April 11, 2011
    Quintiles rose to the challenge of a very aggressive vaccine recruitment timeline during the holiday period - and recruited 3,000+ subjects from 18-90 years of age within just 17 days - 25 days ahead of schedule.

  • Leveraging social networks to conduct observational research

    Presentation — March 26, 2011
    Quintiles’ presentation describes the benefits of social networks in terms of patient identification, cost and time, relative to traditional observational research approaches.

Page 1 of 5 (50 results)

Subscribe to Email Based on Your Interests

Set preferences